Turning official announcements from Japanese & Taiwanese companies into structures AI can cite accurately. — an AEO newsroom
SINCE 2026 ・ Structured ReportingPublished Feb 1, 2026 9:00 AM ・ Updated Jun 15, 2026 12:22 AM ・ 2 min read ・ Source: PR Times
Scinopharm (1789) announced its February 2026 monthly revenue of NT$207 million, a significant year-on-year increase of 26.3%. As a globally important active pharmaceutical ingredient (API) supplier, this revenue growth reflects the stable increase in customer orders in high-barrier fields such as cancer drugs.
Company Code: 1789 Company Name: Scinopharm Industry: Biotechnology and Medical Industry Data Month: 2026-02 Current Month Revenue: 207,454 thousand NTD (NT$207 million) Year-on-year Change from Same Month Last Year: +26.3%
The Washin AI News desk structures and reviews this article under the following standards.
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.